Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model

• मुख्य लेखकों: Yuki Narita (लेखक), Miki Ueda (लेखक), Kohei Uchimura (लेखक), Yutaka Kakizoe (लेखक), Yoshikazu Miyasato (लेखक), Teruhiko Mizumoto (लेखक), Jun Morinaga (लेखक), Manabu Hayata (लेखक), Terumasa Nakagawa (लेखक), Masataka Adachi (लेखक), Taku Miyoshi (लेखक), Yoshiki Sakai (लेखक), Daisuke Kadowaki (लेखक), Sumio Hirata (लेखक), Masashi Mukoyama (लेखक), Kenichiro Kitamura (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2016-02-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

We previously reported that camostat mesilate (CM) had renoprotective and antihypertensive effects in rat CKD models. In this study, we examined if CM has a distinct renoprotective effect from telmisartan (TE), a renin-angiotensin-aldosterone system (RAS) inhibitor, on the progression of CKD. We eva...